Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.
Serie A title hopefuls Atalanta are set to host league giants Juventus in a critical meeting with European implications. Atalanta comes into tonight's clash sitting just five points off the top ...